Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effect of a Transcutaneous Electrical Nerve Stimulation (TENS) Device on Overall Facial Appearance

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01740440
Recruitment Status : Completed
First Posted : December 4, 2012
Results First Posted : March 24, 2016
Last Update Posted : June 30, 2016
Sponsor:
Information provided by (Responsible Party):
Bio-Medical Research, Ltd.

Brief Summary:
Safety and clinical performance of the BMR Face device (manufactured by Bio-Medical Research)

Condition or disease Intervention/treatment Phase
Ageing Device: BMR Face Phase 4

Detailed Description:

Evaluate the efficacy of the BMR Face device in relation to facial appearance at 12 weeks compared to baseline. Efficacy will be assessed by overall facial improvement assessed live by the Investigator and a subject assessment of facial appearance including the Global Aesthetic Improvement Scale (GAIS).

The Global Aesthetic Improvement Scale is a five-grade subjective test. The physician and patient independently describe the degree of improvement in facial appearance. Possible responses were (1) Significantly marked improvement, (2) marked improvement, (3) moderate improvement, (4) slight improvement, (5) no improvement

Secondary objectives are to evaluate safety and further evaluate the subject's and investigator's satisfaction (both a live and blinded assessor) with the BMR Face treatment.


Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 30 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Official Title: Effect of a Transcutaneous Electrical Nerve Stimulation (TENS) Device on Overall Facial Appearance
Study Start Date : November 2012
Actual Primary Completion Date : April 2013
Actual Study Completion Date : April 2013

Arm Intervention/treatment
BMR Face treatment
BMR Face treatment used once a day for 12 weeks
Device: BMR Face
BMR Face used in accordance with manufacturer IFU




Primary Outcome Measures :
  1. Evaluate Overall Facial Improvement Assessed Live by the Investigator and Subjects Using the Global Aesthetic Improvement Scale (GAIS) at 12 Weeks Compared to Baseline. [ Time Frame: 12 weeks ]

    Evaluate the efficacy of the Efficacy will be assessed by overall facial improvement assessed live by the Investigator and a subject assessment of facial appearance including the Global Aesthetic Improvement Scale (GAIS).

    The Global Aesthetic Improvement Scale is a five-grade subjective test. The physician and patient independently describe the degree of improvement in facial appearance. Possible responses were (1) Significantly marked improvement, (2) marked improvement, (3) moderate improvement, (4) slight improvement, (5) no improvement.

    For reporting of outcomes, the higher the GAIS value, the greater the improvement (Range 0-4).



Secondary Outcome Measures :
  1. To Evaluate Overall Facial Improvement Assessed Live by the Investigator and Subjects Including the Global Aesthetic Improvement Scale (GAIS) at 6 Weeks Compared to Baseline [ Time Frame: 6 weeks ]

    Evaluate the efficacy of the Efficacy will be assessed by overall facial improvement assessed live by the Investigator and a subject assessment of facial appearance including the Global Aesthetic Improvement Scale (GAIS).

    The Global Aesthetic Improvement Scale is a five-grade subjective test. The physician and patient independently describe the degree of improvement in facial appearance. Possible responses were (1) Significantly marked improvement, (2) marked improvement, (3) moderate improvement, (4) slight improvement, (5) no improvement.

    For reporting of outcomes, the higher the GAIS value, the greater the improvement (Range 0-4).


  2. To Evaluate the Subject's Satisfaction With BMR Face Treatment at 6 Weeks and 12 Weeks (Subject Self- Assessment). [ Time Frame: 6 weeks, 12 weeks ]
    The Subject Satisfaction Assessment Scale is a 5 point scale where a subject rates their satisfaction level as Very Satisfied, Satisfied, No Opinion, Unsatisfied or Very Unsatisfied.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   35 Years to 55 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Subjects who are able to give voluntary, written informed consent to participate in this study and from whom consent has been obtained including HIPAA authorization
  • Subjects who are healthy females between 35 and 55 years of age
  • Subjects with a Body Mass Index (BMI) between 15-35 kg/m2 (light underweighted to light obese)
  • Subjects may have all skin types
  • Subjects with age related skin laxity in the treatment area
  • Subjects who agree not to have any procedures affecting facial volume (any fillers or fat transfer) for the duration of the study
  • Subjects who agree not to have any other procedures affecting skin quality (microdermabrasion, resurfacing, peels, lasers, acne treatments, etc.) for the duration of the study
  • Subjects who agree to make no changes in their existing skincare regime during the study period
  • Subjects who agree to avoid excessive sun radiation or use appropriate sun protection with SPF 30 or higher
  • Subjects who agree not to alter their diet for the duration of the study
  • Subjects who understand this study and are able to follow study instructions and are willing to attend the required study visits
  • Subjects who agree to be photographed for the purposes of the study and give consent for these photographs to be used in marketing advertisements where their identity will not be concealed in these photographs

Exclusion Criteria:

  • Subjects who are pregnant, planning to become pregnant or breastfeeding. A urine pregnancy test will be done to rule out pregnancy.
  • Subjects of child-bearing potential who are not using an approved method of birth control (oral contraceptives, IUD, contraceptive implant, barrier methods with spermicide or abstinence)
  • Subjects who cannot understand or are not willing to comply with the requirements of the study
  • Subjects who have any dermatologic conditions including acne, rosacea, eczema, psoriasis, severe sun damage or scars within the treatment area
  • Subjects who have any known cancer including skin cancers (Basal Cell Carcinoma, Squamous Cell Carcinoma and Melanoma)
  • Subjects with a history of heart disease or stroke
  • Subjects who have any active implanted medical devices (pacemaker, pump etc)
  • Subjects having any metal implants. Dental implants and fillings are allowed as well as piercings as long as they are not in the treatment area.
  • Subjects who have used a tanning bed in the past four weeks or plan to use a tanning bed for the duration of the study
  • Subjects who are HIV positive
  • Subjects who have had systemic corticosteroid therapy in the past 6 months
  • Subjects who have had a facial dermabrasion, chemical peel, laser, or IPL treatment in the past 6 months
  • Subjects who have used botulinum toxin, hyaluronic acid, collagen, fat injections and /or other methods of skin augmentation (enhancement with injected or implanted material) in the past 6 months
  • Subjects who have had ablative resurfacing procedure, brow lift, blepharoplasty or face lift in treated area in the past 12 months
  • Subjects who have had any other surgery in treated area in the past 12 months
  • Subjects who have an existing medical condition that the Investigator considers may put the subject at risk or compromise their participation in the study
  • Subjects who have participated in another research study in the past 30 days
  • Subjects who are currently involved in any injury litigation claims
  • Subjects who have used the BMR Face device previously

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01740440


Locations
Layout table for location information
United States, New Jersey
Sadick Research Group
New York, New Jersey, United States, 10075
Sponsors and Collaborators
Bio-Medical Research, Ltd.
Investigators
Layout table for investigator information
Principal Investigator: Neil Sadick, Dr Sadick Research Group

Layout table for additonal information
Responsible Party: Bio-Medical Research, Ltd.
ClinicalTrials.gov Identifier: NCT01740440     History of Changes
Other Study ID Numbers: SRG-BMR Face01
First Posted: December 4, 2012    Key Record Dates
Results First Posted: March 24, 2016
Last Update Posted: June 30, 2016
Last Verified: May 2016
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Keywords provided by Bio-Medical Research, Ltd.:
Healthy females
Additional relevant MeSH terms:
Layout table for MeSH terms
Facies
Disease Attributes
Pathologic Processes